Owing to its therapeutic potential in inflammatory diseases like psoriasis, ulcerative colitis, liver and pancreatic damage, graft-versus-host disease, certain infections and tumors, and its association with disease staging, IL-22 can prove to be useful for therapeutic and prognostic purposes in the future. This evidence concerns the gene IL22 and graft versus host disease.